As the global Life Science sector continues to grow, the world’s leading pharmaceutical companies are looking beyond traditional markets for growth. However, the industry faces challenges – expiring patents, pricing pressure, and growing regulation in various markets. Pharmaceutical markets need globalized, traceable, secure and compliant supply chains with end to end visibility.
Agility’s solutions meet the unique requirements of the pharmaceutical industry by providing a range of services, including storage in multiple temperature zones, cold-chain solutions, reverse logistics and advanced tracking and tracing technologies, which ensure total supply chain visibility, and reporting on merchandise flows across all modes of transport.
An Example Supply Chain Solution
An end-to-end look
GDP-Compliant Pharmaceutical Competence Centre
Trained Warehouse Staff
Supply Chain Visibility
Agility Derisks Pharmaceutical Supply Chains
Agility Risk Mitigations
Rapid introduction of new legislation and regulations
A global network of pharma supply chain experts, continuously trained and committed to compliance with international regulations like Good Distribution Practice (GDP).
Fragile supply chain security, leading to theft and distribution of counterfeit pharmaceuticals.
Full visibility throughout the supply chain with security analysis, supplier evaluation and track-and-trace technology.
Increased demand for temperature control equipment with the introduction of the Controlled Room Temperature (CRT) regulation
Full range of active and passive packaging solutions to ensure the right service level at all times considering product stability, regulation and cost.
A fragile supply chain security, leading to theft and distribution of counterfeit pharmaceuticals.
Cargo consolidation solutions and reducing costs through transport mode and routing optimization.
Fragile or incomplete supply chain has a potential risk of dramatic harm to patients
Global medicine spending forecast to reach nearly $1.3 trillion by 2022
6 to 15 times
An international pharmaceutical shipment exchanges hands six to 15 times en route to a patient
1 in 10 medical products
An estimated 1 in 10 medical products in low and middle income countries is substandard or falsified
It’s estimated that over one million people die each year from fake drugs